Publication:
Do intracerebral cytokine responses explain the harmful effects of dexamethasone in human immunodeficiency virus–associated cryptococcal meningitis?

dc.contributor.authorJustin Beardsleyen_US
dc.contributor.authorNhat L.T. Hoangen_US
dc.contributor.authorFreddie M. Kibengoen_US
dc.contributor.authorNguyen L.N. Tungen_US
dc.contributor.authorTran Q. Binhen_US
dc.contributor.authorLe Q. Hungen_US
dc.contributor.authorWirongrong Chierakulen_US
dc.contributor.authorGuy E. Thwaitesen_US
dc.contributor.authorNguyen V.V. Chauen_US
dc.contributor.authorThuong T.T. Nguyenen_US
dc.contributor.authorRonald B. Geskusen_US
dc.contributor.authorJeremy N. Dayen_US
dc.contributor.otherCho Ray Hospitalen_US
dc.contributor.otherThe University of Sydneyen_US
dc.contributor.otherUCLen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherLSHTM Uganda Research Uniten_US
dc.contributor.otherOxford University Clinical Research Uniten_US
dc.date.accessioned2020-01-27T10:40:22Z
dc.date.available2020-01-27T10:40:22Z
dc.date.issued2019-01-01en_US
dc.description.abstract© The Author(s) 2018. Background. The CryptoDex trial showed that dexamethasone caused poorer clinical outcomes and slowed fungal clearance in human immunodeficiency virus–associated cryptococcal meningitis. We analyzed cerebrospinal fluid (CSF) cytokine concentrations from participants over the first week of treatment to investigate mechanisms of harm and test 2 hypotheses: (1) dexamethasone reduced proinflammatory cytokine concentrations, leading to poorer outcomes and (2) leukotriene A4 hydrolase (LTA4H) genotype influenced the clinical impact of dexamethasone, as observed in tuberculous meningitis. Methods. We included participants from Vietnam, Thailand, and Uganda. Using the Luminex system, we measured CSF concentrations of the following: interferon γ, tumor necrosis factor (TNF) α, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant 1, macrophage inflammatory protein 1α, and interleukin 6, 12p70, 8, 4, 10, and 17. We determined the LTA4H genotype based on the promoter region single-nucleotide polymorphism rs17525495. We assessed the impact of dexamethasone on cytokine concentration dynamics and the association between cytokine concentration dynamics and fungal clearance with mixed effect models. We measured the influence of LTA4H genotype on outcomes with Cox regression models. Results. Dexamethasone increased the rate TNF-α concentration’s decline in (−0.13 log2pg/mL/d (95% confidence interval, −.22 to −.06 log2pg/mL/d; P = .03), which was associated with slower fungal clearance (correlation, −0.62; 95% confidence interval, −.83 to −.26). LTA4H genotype had no statistically significant impact on outcome or response to dexamethasone therapy. Better clinical outcomes were associated with higher baseline concentrations of interferon γ. Conclusions. Dexamethasone may slow fungal clearance and worsen outcomes by increasing TNF-α concentration’s rate of decline.en_US
dc.identifier.citationClinical Infectious Diseases. Vol.68, No.9 (2019), 1494-1501en_US
dc.identifier.doi10.1093/cid/ciy725en_US
dc.identifier.issn15376591en_US
dc.identifier.issn10584838en_US
dc.identifier.other2-s2.0-85067391314en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/52382
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067391314&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleDo intracerebral cytokine responses explain the harmful effects of dexamethasone in human immunodeficiency virus–associated cryptococcal meningitis?en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067391314&origin=inwarden_US

Files

Collections